Cargando…
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant clonal disorder that progresses to multiple myeloma (MM), or other plasma-cell or lymphoid disorders at a rate of 1%/year. We evaluate the contribution of body mass index (BMI) to MGUS progression beyond established clinical...
Autores principales: | Kleinstern, Geffen, Larson, Dirk R., Allmer, Cristine, Norman, Aaron D., Muntifering, Grace, Sinnwell, Jason, Visram, Alissa, Rajkumar, Vincent, Dispenzieri, Angela, Kyle, Robert A., Slager, Susan L., Kumar, Shaji, Vachon, Celine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018764/ https://www.ncbi.nlm.nih.gov/pubmed/35440099 http://dx.doi.org/10.1038/s41408-022-00659-9 |
Ejemplares similares
-
Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method
por: Vachon, Celine M., et al.
Publicado: (2022) -
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Pang, Li, et al.
Publicado: (2021) -
Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS)
por: Zushi, Yuriko, et al.
Publicado: (2019) -
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6
por: Clay-Gilmour, Alyssa, et al.
Publicado: (2022) -
A Case of Crystalline Keratopathy in Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Koo, Hyun, et al.
Publicado: (2011)